The EPS projection of Evolent Health Inc (NYSE:EVH) for quarter ended 2016-09-30 is $-0.15. A week before, the EPS forecast was $-0.15 against target of $-0.15, a month earlier. This estimate stood at $-0.15 60 days earlier versus forecast of $-0.15 90 days earlier, confirming a deviation of 0%.
Evolent Health Inc (NYSE:EVH) reported that 18 days ago, the positive EPS revisions were 1 and negative revisions at 1.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 1, 1, 1 and 1, respectively.
The downgrade of EPS estimates for Evolent Health Inc (NYSE:EVH) in the preceding 120, 60, 30 and 90 days were 1, 4, 0 and 2, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of Evolent Health Inc (NYSE:EVH) was $-0.15. This projection was computed after accounting 5 calls. As reported on 2016-05-12 the EPS was $-0.27. The change was $-0.08, demonstrating a percentage deviation of -42.11%. The projections confirmed a standard deviation of 0.02.
Quarterly Sales Estimates
For the fiscal 2016, the yearly sales target for Evolent Health Inc (NYSE:EVH) stands at $60.034 and the median estimate at $60.2. Almost 5 analysts announced their estimates.
The highest estimate is $60.4 while the lowest target is $59.1 showing standard deviation of 0.528%.
As many as 5 analysts released sales estimates reised in upside while 5 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 5 revised sales number projection on upside while 5 lowered the sales target, demonstrating a deviation of -2.715%.
A quarter ago, 5 hiked sales estimations and 5 reduced sales forecast. Evolent Health Inc (NYSE:EVH) stated that the change in forecast was -2.17%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...